Osman Moneer
@osmanmoneer
Followers
253
Following
551
Media
5
Statuses
58
@StanfordMed Internal Medicine Resident. Formerly @YaleMed and @Columbia. he/him/his.
Joined February 2020
We’re moving to California! So excited to match at @StanfordDeptMed for Internal Medicine residency!!
46
191
4K
RT @Yale_CRRIT: Latest in @JAMANetworkOpen: @MedicareGov's Coverage with Evidence Development (CED) program has commissioned 116 clinical s….
0
3
0
RT @Yale_CRRIT: It isn’t always clear whether a new drug or device is effective. When in doubt, @CMSGov can insure a product for further st….
0
2
0
RT @Yale_CRRIT: In @Health_Affairs, we analyzed the availability and quality of recent @MedicareGov Local Coverage Determination decisions.….
0
2
0
CMS should consider strengthening premarket evidence requirements to ensure that supplemental payments are reserved for technologies that meaningfully enhance the care of Medicare beneficiaries.
1
0
1
We found that devices approved for supplemental payments more commonly received FDA authorization based on premarket clinical studies. However, these studies often lacked generalizability to Medicare beneficiaries, used surrogate measures, or didn't meet all primary endpoints.
1
0
1
To facilitate adoption of new medical devices, CMS can award💰 extra payments 💰 on top of standard reimbursement. In JAMA Health Forum, we characterized the evidence considered by CMS when approving or denying applications for outpatient Medicare supplemental payments.
2
1
4
RT @JAMAHealthForum: Centers for Medicare & Medicaid Services (CMS) should consider strengthening premarket evidence requirements for break….
0
2
0
RT @ellelandegife: I am so thrilled to be joining the @StanfordCTSurg family with @osmanmoneer by my side!!! Many thanks to all the mentors….
0
57
0
RT @JAMACardio: The Breakthrough Devices Program may qualify new, costly devices for supplemental Medicare payment despite the evidence sup….
0
1
0
Fortunate to have worked with such an amazing team of co-authors!!. Kudos to Vinay Rathi (@MassEyeAndEar), @JLJohnstonMD (@BrighamMedRes), @jsross119 (@Yale_CRRIT), and Sanket Dhruva (@UCSFCardiology).
0
0
3
Along with an editor's note from @JAMACardio's @NMHheartdoc, Patrick O'Gara, and Robert Bonow contextualizing our work:.
1
1
3
With an excellent accompanying editorial from former Chief Medical Officer and Director of the Center for Clinical Standards and Quality at CMS @LeeAFleisher: .
1
0
3
How can FDA & CMS align policies to ensure that medical device innovation is based on strong and representative evidence? . In a new @JAMACardio Special Communication, we explore market authorization and coverage for Breakthrough cardiovascular🫀 devices.
1
7
19
RT @Yale_CRRIT: Many thanks to this great group & @Arnold_Ventures for a terrific past 2 days of engaging dialogue on all aspects of FDA ad….
0
9
0
Check out our opinion piece in @bmj_latest! . We discuss the challenges of evidence generation for Covid-19 drugs and suggest a role for observational studies in pandemic decision-making. @JoshuaDWallach @jsross119 .
0
5
11
RT @JoshuaDWallach: In this @bmj_latest linked Opinion, we discuss our recent manuscript, some challenges, and when observational studies c….
0
4
0
RT @bmj_latest: The urgency of the covid-19 pandemic highlighted the need to leverage any and all available data that may potentially infor….
0
5
0
RT @ellelandegife: Thrilled to represent @YaleCardiacSurg at #AATS2022 with our presentation on TAVR explantation! Grateful for the support….
0
10
0